Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about ResMed Inc.
ResMed Inc. News
Dec 11, 2025 - defenseworld.net
First Trust Advisors LP Acquires 3,390 Shares of ResMed Inc. $RMD
Dec 9, 2025 - zacks.com
RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort
Dec 8, 2025 - seekingalpha.com
Top 50 High-Quality Dividend Growth Stocks For December 2025
Dec 8, 2025 - globenewswire.com
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
ResMed Inc. Quantitative Score

About ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
ResMed Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
ResMed Inc. Financials
Table Compare
Compare RMD metrics with: | |||
|---|---|---|---|
Earnings & Growth | RMD | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | RMD | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | RMD | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | RMD | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
ResMed Inc. Income
ResMed Inc. Balance Sheet
ResMed Inc. Cash Flow
ResMed Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
ResMed Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 2.2600 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-12-18 | 0.6 | Quarterly |
| 2025-09-18 | 0.6 | Quarterly |
| 2025-06-12 | 0.53 | Quarterly |
| 2025-03-20 | 0.53 | Quarterly |
| 2024-12-12 | 0.53 | Quarterly |
Historical Market Cap
Shares Outstanding
ResMed Inc. Executives
| Name | Role |
|---|---|
| Mr. Michael J. Farrell BE, MBA, SM | Chief Executive Officer & Chairman |
| Mr. Justin Leong | Chief Product Officer |
| Mr. Brett A. Sandercock | Chief Financial Officer |
| Mr. Michael J. Rider | Chief Legal Officer & Secretary |
| Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus & Non-Executive Director |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Michael J. Farrell BE, MBA, SM | Chief Executive Officer & Chairman | Male | 1972 | 2.97M |
| Mr. Justin Leong | Chief Product Officer | Male | 1977 | 1.31M |
| Mr. Brett A. Sandercock | Chief Financial Officer | Male | 1967 | 971.97K |
| Mr. Michael J. Rider | Chief Legal Officer & Secretary | Male | 1958 | 889.12K |
| Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus & Non-Executive Director | 1942 | 413.22K |
ResMed Inc. Insider Trades
| Date | 8 Dec |
| Name | Farrell Michael J. |
| Role | Chairman and CEO |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 4991 |
| Date | 8 Dec |
| Name | Farrell Michael J. |
| Role | Chairman and CEO |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 4991 |
| Date | 8 Dec |
| Name | Farrell Michael J. |
| Role | Chairman and CEO |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 4991 |
| Date | 3 Dec |
| Name | FARRELL PETER C |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 2000 |
| Date | 1 Dec |
| Name | Rider Michael J |
| Role | Global General Counsel |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 50 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 8 Dec | Farrell Michael J. | Chairman and CEO | Acquired | M-Exempt | 4991 |
| 8 Dec | Farrell Michael J. | Chairman and CEO | Disposed | S-Sale | 4991 |
| 8 Dec | Farrell Michael J. | Chairman and CEO | Disposed | M-Exempt | 4991 |
| 3 Dec | FARRELL PETER C | Director | Disposed | S-Sale | 2000 |
| 1 Dec | Rider Michael J | Global General Counsel | Disposed | S-Sale | 50 |